How Close Strategic Partnering And The ‘Value Proposition Approach’ Changes The Relationship Between Pharma Clients And Their Customers
- Examining in-house versus outsourced R&D, and how the decision between the two is impacted by COVID-19
- Exploring changing approaches to how pharma companies’ evaluate the work of CDMO suppliers: the value proposition approach
- Strategies for value proposition: open book calculations, buying of capacity, greater visibility, and effective supply chain management
- How to find the best CDMO in the jungle of potential partners? Perspectives from both insourcing and outsourcing experience